Yea Christopher Insider Trades

Insider Trading History

Track insider trading activity for Yea Christopher. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.13M 227,367 shares
Last Trade
May 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$29.7k 1,108 shares
$26.76
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.16M 228,475 shares
Last Trade
May 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.4k 1,774 shares
$26.73
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $0 0 shares
Last Trade
May 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$47.4k 1,774 shares
$26.73
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.11M 226,701 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$67.7k 4,347 shares
$15.57
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $758k 28,125 shares
Last Trade
Feb 22, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,125 shares
$15.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.23M 231,048 shares
Last Trade
Feb 22, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.5k 3,125 shares
$15.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.14M 227,923 shares
Last Trade
Feb 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 3,750 shares
$15.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $1.21M 45,000 shares
Last Trade
Feb 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59.4k 3,750 shares
$15.83
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.04M 224,173 shares
Last Trade
Feb 18, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.6k 1,109 shares
$15.00
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.07M 225,282 shares
Last Trade
Feb 17, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.6k 1,774 shares
$14.99
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $47.8k 1,774 shares
Last Trade
Feb 17, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$26.6k 1,774 shares
$14.99
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.02M 223,508 shares
Last Trade
Nov 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.3k 4,331 shares
$13.45
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $842k 31,250 shares
Last Trade
Nov 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.9k 3,125 shares
$13.10
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.14M 227,839 shares
Last Trade
Nov 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$40.9k 3,125 shares
$13.10
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $1.31M 48,750 shares
Last Trade
Nov 21, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.1k 3,750 shares
$13.10
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $6.06M 224,714 shares
Last Trade
Nov 21, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49.1k 3,750 shares
$13.10
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $5.95M 220,964 shares
Last Trade
Nov 20, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 87,390 shares
$13.02
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $0 0 shares
Last Trade
Nov 20, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.14M 87,390 shares
$13.02
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $3.6M 133,574 shares
Last Trade
Nov 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$38.8k 2,683 shares
$14.48
$26.95
KalVista Pharmaceuticals
KalVista Pharmaceuticals KALV
CHIEF DEVELOPMENT OFFICER
Holding Value $95.6k 3,548 shares
Last Trade
Nov 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$62.5k 4,205 shares
$14.86
$26.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up